Duvelisib (IPI-145)

Duvelisib is an orally bioavailable and selective small molecule inhibitor of phosphoinositide 3-kinase (PI3K) delta and gamma isoforms with potential immunomodulatory and anti-tumor activity.
Supplier Alfa Cytology
Product # BC0143
Pricing 25.0 mg, 50.0 mg, 100.0 mg, 200.0 mg, 500.0 mg, 1.0 g, 2.0 g, inquire
Feedback